Skip to content
akaturk Academic measurement
2025 SJR Q3 JCR Q2 · 2,3 OA 11 matched articles

Journal detail

International Journal of Rheumatology

Publisher
John Wiley and Sons Ltd
Country
United States · Northern America
Type
journal
ISSN
  • 16879260
  • 16879279
Scopus 0,457 SJR
Scopus Q3 SJR Q
WoS Q2 JCR Q
WoS 2,3 JIF
Scopus 44 H-Index

Integrated evaluation

Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.

WoS / JCR data covers 1997 onward.

Scopus

Scopus · Scimago

  • SJR 0,457
  • Quartile Q3
  • H-Index 44
  • Cites/doc 2,25
  • Docs (3y) 21
  • Cites (3y) 42

Clarivate

Web of Science · JCR · 2023

  • JCR Q Q2
  • JIF 2,3
  • 5Y JIF 2,1
  • JCI 0,48

Subject classification

Categories (SJR)

  • Immunology Q3
  • Rheumatology Q3

Areas

  • Immunology and Microbiology
  • Medicine

Yearly quartile comparison

Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.

WoS / JCR data covers 1997 onward.

Note: JCR Q, JIF, 5Y JIF, JCI, and JCI Q are blank before 1997 — WoS/JCR data on this site starts in 1997.
Year SJR Q JCR Q (1997+) SJR JIF (1997+) 5Y JIF (1997+) JCI (1997+) JCI Q (1997+) H-Index
2025 Q3 — 0,457 — — — — 44
2024 Q3 — 0,572 — — — — 43
2023 Q3 Q2 0,644 2,3 2,1 0,48 Q3 43
2022 Q3 — 0,365 2,3 2,4 0,46 Q3 43
2021 Q3 — 0,366 — — 0,45 Q3 43
2020 Q3 — 0,8 — — 0,42 Q3 43
2019 Q2 — 0,663 — — — — 43
2017 Q2 — 0,645 — — — — 43
2016 Q2 — 0,667 — — — — 43
2015 Q1 — 1,253 — — — — 43
2014 Q2 — 0,822 — — — — 43
2013 Q2 — 0,796 — — — — 43
2012 Q2 — 0,463 — — — — 43
2011 Q3 — 0,283 — — — — 43
2010 — — — — — — — 43

JCR category quartile history

JCR / JCI quartile by year and category. 1997 and later.

WoS / JCR data covers 1997 onward.

Note: This table shows Clarivate category quartile records from 1997 onward.
Year Category Edition JCR Q (1997+) JCI Q (1997+) Rank
2023 RHEUMATOLOGY ESCI Q2 Q3 28/57
2022 RHEUMATOLOGY ESCI — Q3 —
2021 RHEUMATOLOGY ESCI — Q3 —
2020 RHEUMATOLOGY ESCI — Q3 —